U.S. increases order of Moderna mRNA COVID-19 vaccine to 300M doses

By The Science Advisory Board staff writers

January 27, 2021 -- Moderna is in discussion with the U.S. government for the purchase of an additional 100 million doses of its messenger RNA (mRNA) COVID-19 vaccine, mRNA-1273, for delivery in the third quarter of 2021.

To date, the U.S. has agreed to purchase 200 million doses of the Moderna COVID-19 vaccine, and this new purchase would bring the total to 300 million doses. The company plans on using its U.S.-based manufacturing capabilities to supply the vaccine to the U.S. government.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.